Sharpless lists initial priorities for NCI: Big Data, cell therapy, and more trials at the NIH Clinical Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI needs to focus on developing a structured approach to Big Data initiatives to ensure optimal use of the institute’s limited resources, said NCI Director Norman “Ned” Sharpless at his first joint meeting of the National Cancer Advisory Board and the Board of Scientific Advisors.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Matthew Bin Han Ong
Senior Editor

YOU MAY BE INTERESTED IN

Matthew Bin Han Ong
Senior Editor

Login